These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


875 related items for PubMed ID: 9317068

  • 1. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F, Moum B, Haug JB, Tolås P, Breder O, Aubert E, Høie O, Søberg T, Flaaten B, Farup P, Berge T.
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q, Pan Y, Zhang L, Xiao SD.
    Chin J Dig Dis; 2005 Nov; 6(4):202-5. PubMed ID: 16246231
    [Abstract] [Full Text] [Related]

  • 10. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1315-21. PubMed ID: 15191514
    [Abstract] [Full Text] [Related]

  • 12. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 15; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 13. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar 15; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 14. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar 15; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 15. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A.
    Med Clin (Barc); 1998 Jan 17; 110(1):1-5. PubMed ID: 9527978
    [Abstract] [Full Text] [Related]

  • 16. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M, Archimandritis A, Balatsos V, Delis V, Souyioultzis S, Skandalis N, Kanellopoulou E, Manika Z, Davaris P.
    Eur J Gastroenterol Hepatol; 1997 Dec 17; 9(12):1185-9. PubMed ID: 9471024
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A.
    J Gastroenterol; 2004 Oct 17; 39(10):927-30. PubMed ID: 15549444
    [Abstract] [Full Text] [Related]

  • 18. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
    Lara LF, Cisneros G, Gurney M, Van Ness M, Jarjoura D, Moauro B, Polen A, Rutecki G, Whittier F.
    Arch Intern Med; 2003 Sep 22; 163(17):2079-84. PubMed ID: 14504122
    [Abstract] [Full Text] [Related]

  • 19. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun 22; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 20. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
    Chu KM, Kwok KF, Law SY, Wong J.
    Hepatogastroenterology; 2000 Jun 22; 47(36):1624-6. PubMed ID: 11149018
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.